Medindia

X

IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment

Thursday, June 2, 2011 General News J E 4
Advertisement
IDE Study Examines Performance of SUPERA® Stent in Superficial Femoral Artery (SFA)

Contact:

Donna Lucchesi

Vice President Global Marketing

IDEV Technologies, Incorporated

(281) 525-2000

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Marshall Edwards Adds Former Genentech Head of Med...
S
Synutra to Announce Fourth Quarter and Full Year F...